CLASS II ONGOING Device recall · Reported 8 Apr 2026 · FDA Enforcement Report

Cardinal Health Monoject Tuberculin Syringe Luer Lock recalled

Cardinal Health 200 is recalling Cardinal Health Monoject Tuberculin Syringe Luer Lock, distributed nationwide in the US. The recall was initiated on 27 Feb 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 10884521013414 (each), 20884521013411 (box), 30884521013418 (case), Lot Numbers: 531164X, 531162X
Quantity recalled198,900 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1768-2026
FDA event ID
98534
Recalling firm
Cardinal Health 200, Waukegan, IL
Classification
Class II
Status
Ongoing
Recall initiated
27 Feb 2026
FDA classified
2 Apr 2026
Reported
8 Apr 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

27 Feb 2026Recall initiated by company
2 Apr 2026Classified by FDA+34 days
8 Apr 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777

Where it was distributed

Worldwide distribution - US Nationwide and the country of Canada.

Nationwide

Questions about this recall

Why was it recalled?

The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.

Which lots are affected?

UDI/DI 10884521013414 (each), 20884521013411 (box), 30884521013418 (case), Lot Numbers: 531164X, 531162X

Where was it sold?

Worldwide distribution - US Nationwide and the country of Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cardinal Health 200

All 290

Other Syringes & Needles recalls

All 1,066